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 Survival rates after out-of-hospital cardiac arrest (OHCA) vary considerably 
worldwide and are highly dependent on the organization of emergency medical services 
(EMS), rates of bystander performing cardiopulmonary resuscitation (CPR), time to first 
defibrillation, quality of advanced life support (ALS) and post resuscitation care, i.e. the 
quality of the local chain of survival (LOS) (1). Health care systems that have implemented 
rigorous training and monitoring systems to strengthen weak links in the local LOS have 
arguably had the greatest impact on survival from cardiac arrest (2).                
Given that early bystander CPR improves survival after cardiac arrest (3), CPR 
training for all should start at school age, not only to ensure early initiation of CPR, but also 
for early recognition of cardiac arrest and rapid alerting of the emergency medical 
communication centres (EMCC). Global positioning system (GPS)-enabled mobile-phones 
are already being used to dispatch trained lay volunteers to OHCA victims, thereby increasing 
rates of bystander-initiated CPR (4). By 2050, it is likely that enhancements in GPS and 
mobile communications will enable much faster and more precise responses by lay trained 
volunteers (Table 1). Early defibrillation improves survival and by 2050 we expect 
widespread deployment of relatively inexpensive and more sophisticated automated external 
defibrillators (AEDs) beyond the traditional first responders inside the EMS systems, thus 
decreasing the distance to the closest AED (5,6). Drones that can carry AEDs to the scene of a 
cardiac arrest are already being developed and by 2050 it is likely that EMMCs will have 
fully adopted this technology (7). In the future, the EMCCs will have highly effective 
protocols for identifying cardiac arrest and for providing telephone-guided CPR. Wireless 
technology and the use of biosensors are evolving rapidly – in the future it is likely that a 
patient with an impending OHCA can be detected remotely and then treated so that cardiac 
arrest is prevented.  
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ALS providers should focus on good quality CPR, defibrillation, airway management, 
drug therapy and use of more advanced adjuncts that might further improve haemodynamics 
(8). However, ALS will evolve beyond routine use of standardised drugs with a ‘one size fits 
all’ philosophy. Instead of using a standardised algorithm, injection of vasopressors is likely 
to be guided by the haemodynamic response, such as the diastolic aortic pressure (9). 
Furthermore, the timing of drug delivery as well as the drugs used (e.g., vasopressors, 
antiarrhythmics) will be individualised. Use of technologies such as capnography, near 
infrared spectrophotometry (NIRS), waveform analysis for optimizing shock delivery, (8) 
carotid Doppler blood flow measurements (10) and ultrasound examination (8) will enable 
haemodynamics during CPR to be optimised and individualised taking into account the cause 
of cardiac arrest. Use of more sophisticated mechanical chest compression devices is likely to 
become more widespread, either as a bridge to coronary angiography/percutaneous coronary 
intervention or to extracorporeal CPR (ECPR). By 2050, it is likely to be much easier to 
undertake ECPR for the treatment of refractory cardiac arrest, and therefore extending its 
existing availability from tertiary centres to most acute hospitals (11).  
Most patients who have an in-hospital cardiac arrest (IHCA) will show signs of 
deterioration in the hours preceding the event. The most effective way of reducing mortality 
from IHCA is to recognise those at risk of cardiac arrest and either treat to prevent the cardiac 
arrest or make a do not attempt CPR (DNACPR) decision. By 2050, electronic medical 
records will be implemented widely, enabling automatic capture of vital sign data from 
wireless monitors and derivation of automated early warning scores. Such systems will enable 
efficient automatic alerting of the rapid response team that can then intervene and potentially 
prevent cardiac arrest. By 2050, the wide adoption of emergency care and treatment plans will 
mean that most in-patients will have discussed with hospital staff and agreed their emergency 
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treatment, including CPR, in advance. This will reduce or, ideally, eliminate futile 
resuscitation attempts in hospital. 
When return of spontaneous circulation (ROSC) is obtained, finding and treating the 
cause of the cardiac arrest can prevent relapse and subsequent clinical deterioration. In this 
way, recent guidelines recommend that resuscitated patients of presumed coronary cause 
should undergo immediate coronary angiography with subsequent revascularisation if 
indicated (12). Although it presents some organisational challenges, a 24/7 coronary 
angiography should make available in all our future cardiac arrest centres. The principle 
challenge is to identify those cardiac arrest patients with a presumed coronary cause and to 
avoid taking patients without acute culprit lesions to coronary angiography. We hope that the 
future will give us better diagnostic tools (transportable CT, handheld echocardiography, 
early biomarkers), because an early ECG, performed on the scene of resuscitation 
immediately after ROSC, is insufficiently precise to detect or exclude acute culprit lesions 
responsible for the arrest. (13).  Furthermore, it will become much easier to perform a 
coronary CT-scan at the time of hospital admission. This non-invasive strategy could be used 
in ‘low-risk patients’ (i.e., those without evidence of a coronary cause), since it will be 
possible to avoid further invasive procedures in those with a normal coronary CT-scan (14).  
Post-resuscitation brain injury is the commonest cause of death following OHCA. 
Today, the only way to maximise neurological recovery is to lower the body temperature after 
hospital admission, even if the optimal target is still debated (between 32 and 36 °C). The 
severity of the reperfusion injury, which is dependent on the cause of arrest, pre-arrest 
condition, anoxia time, time to ROSC, and quality of CPR/ALS, should probably prompt 
different treatment options and not the ‘one size fits all’ strategy that we follow today. Novel 
cooling techniques will be able to provide ultrafast cooling, which has proven highly efficient 
in animal experiments, even intra-arrest, and this will perhaps provide us with more answers. 
 5 
In 2050, it will also be possible to combine TTM with pharmacological neuroprotection, and, 
the use of inhaled noble gases (particularly xenon) is probably one of the most exciting 
ongoing research programs (15). Finally, early neuroprognostication will be facilitated by 
using a well-established algorithm combining clinical data, biomarkers, electrophysiology 
(continuous EEG and evoked potentials) and brain magnetic resonance imaging. Importantly, 
both timing and methods are crucial to avoid self-fulfilling prophecy (12).  
 Efficacy (explanatory) trials examine interventions under ideal and controlled 
circumstances and by using narrow inclusion criteria tend to involve relatively homogeneous 
populations. Effectiveness (pragmatic) trials evaluate interventions in real-life settings. The 
high mortality and the heterogeneity of cardiac arrest patients can make it challenging to 
demonstrate significant differences between control and intervention groups in effectiveness 
trials. This might be partly because most included patients already have irreversible 
neurological injury before randomisation and treatment allocation. In the future, new 
approaches to the design of clinical trials in resuscitation (e.g. adaptive trial design) may 
improve efficiency and produce more meaningful results.  
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Table 1. Chain of survival in 2050 
 
Early recognition and alert 
Wireless biosensors in high-risk patients 
Widespread education of public 
Use of GPS systems 
  
Defibrillation 
Widespread deployment of AEDs 
AEDs delivery by drones 
Waveform analysis guided defibrillation 
  
Advanced life support 
Goal-directed resuscitation 
Ultrasound examination 
Fast ECPR in refractory cases 
  
Post-resuscitation care 




GPS: global positioning systems 
AED: automated external defibrillators 
ECPR: extra-corporeal resuscitation 
 
 
 
